<DOC>
	<DOCNO>NCT00799565</DOCNO>
	<brief_summary>This prospective nation-wide ( France ) study aim search susceptibility gene MVP use genome wide analysis compare result obtained 1000 patient MVP 1000 non-MVP subject .</brief_summary>
	<brief_title>Mitral Valve Prolapse ( MVP ) - France Study</brief_title>
	<detailed_description>Two MVP population define study , either classical Barlow ( myxomatous ) disease fibroelastic degenerescence ( thin redundant leaflet ) . MVP adult patient ( &gt; 18 year-old ) include present follow 1 ) 2 ) criterion : 1 . 2D-echocardiographic mitral leaflet prolapse parasternal long-axis view &gt; 2 mm AND leaflet thickness &gt; 4 mm mitral regurgitation &gt; 2 + ( use color Doppler ) 2 . Previous surgery pure severe mitral regurgitation due MVP Barlow disease fibroelastic degenerescence ( operative report available ) Patients exclude case associate heart disease ( hypertrophic cardiomyopathy , rheumatismal disease… ) syndromic disease ( Marfan , Ehlers-Danlos… ) . Around 30 ( cardiology , cardiovascular surgery ) french center participate study . An e-CRF used collect clinical data . A genetic core lab collect DNA sample . An echocardiographic core lab collect read echo recording . DNA analysis compare patient group spouses patient used control . In case inadequacy concern group size age , available genotyped cohort use .</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Mitral Valve Prolapse</mesh_term>
	<criteria>Inclusion criterion MVP patient : Male female subject ≥18 year Affiliation French social insurance system Written inform consent Idiopathic MVP define presence criterion 1 ) 2 ) OR criterion 3 ) : 1 . Echographic MVP &gt; 2 mm leave ventricular parasternal longaxis view 2 . Echographic myxomatous valve ( thickness &gt; 4 mm ) significant mitral regurgitation ( &gt; 2 + use color Doppler ) 3 . History mitral valve surgery pure mitral regurgitation due MVP ( myxomatous fibroelastic deficiency ) available detailed operative report . Exclusion criterion : Presence heart disease cause MVP ( rheumatic , HCM… ) Syndromic disease ( Marfan , EhlersDanlos… ) Inclusion criterion healthy subject : Male female subject ≥40 year Absence MVP absence mitral valve dystrophy Caucasian</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Mitral Valve prolapse</keyword>
	<keyword>echography</keyword>
	<keyword>genetic study</keyword>
	<keyword>study case-witness</keyword>
	<keyword>Patients Mitral Valve Prolapse</keyword>
</DOC>